This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

US federal court closes door on PREP Act immunity for patent infringement

By Nick Robertson ( July 28, 2025, 22:33 GMT | Insight) -- Pharmaceutical companies and medical device manufacturers can't claim immunity from patent infringement claims under the Public Readiness and Emergency Preparedness Act, a Maine federal judge ruled. The decision, likely headed to the US Federal Circuit, limits pharmaceutical and medical device companies’ infringement defenses amidst public health emergencies.A Maine federal judge ruled Friday that the Public Readiness and Emergency Preparedness  Act’s liability shield doesn't extend to claims of patent infringement....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections